title: TNF-α mediates increased susceptibility to ischemic AKI in diabetes.
abstract: Diabetes is a risk factor for the development of acute kidney injury (AKI) in humans and rodents. However, the mechanistic basis for this observation is unknown. The present studies evaluated the role of inflammation and TNF-α in ischemic AKI in a model of type 2 diabetes mellitus (DM). Diabetic (db/db) and nondiabetic (db/+) littermates were subjected to 20 min of bilateral renal ischemia. The nondiabetic mice developed only mild and transient renal dysfunction. In contrast, the equivalent ischemic insult provoked severe and sustained renal dysfunction in the db/db mice. The expression of TNF-α and Toll-like receptor 4 (TLR4) mRNA was measured in the kidneys of diabetic mice before and after renal ischemia; db/db mice exhibited greater increases in TNF-α and TLR4 mRNA expression following ischemia than did db/+. In addition, urinary excretion of TNF-α after ischemia was higher in db/db mice than in db/+ mice. To determine the possible role of TNF-α in mediating the enhanced susceptibility of diabetic mice to ischemic injury, db/db mice were injected with either a neutralizing anti-mouse TNF-α antibody or nonimmune globulin and then subjected to 20 min of bilateral renal ischemia. Treatment of the db/db mice with the TNF-α antibody provided significant protection against the ischemic injury. These data support the view that diabetes increases the susceptibility to ischemia-induced renal dysfunction. This increased susceptibility derives from a heightened inflammatory response involving TNF-α and perhaps TLR4 signaling.
authors.affiliation: Div. of Nephrology, Rm. C5830, Penn State College of Medicine, 500 Univ. Dr., Hershey, PA 17033, USA. ggao@hmc.psu.edu
authors.forename: Guofeng
authors.initials: G
authors.lastname: Gao
authors.forename: Binzhi
authors.initials: B
authors.lastname: Zhang
authors.forename: Ganesan
authors.initials: G
authors.lastname: Ramesh
authors.forename: Daniel
authors.initials: D
authors.lastname: Betterly
authors.forename: Raghu K
authors.initials: RK
authors.lastname: Tadagavadi
authors.forename: Weiwei
authors.initials: W
authors.lastname: Wang
authors.forename: W Brian
authors.initials: WB
authors.lastname: Reeves
mesh_terms: D058186:Acute Kidney Injury / Q000150:complications / Q000378:metabolism* / Q000503:physiopathology; D000818:Animals; D057134:Antibodies, Neutralizing; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism* / Q000503:physiopathology; D004198:Disease Susceptibility; D007249:Inflammation / Q000150:complications / Q000378:metabolism / Q000503:physiopathology; D007511:Ischemia / Q000150:complications / Q000378:metabolism* / Q000503:physiopathology; D007668:Kidney / Q000098:blood supply / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D051379:Mice; D051197:Toll-Like Receptor 4 / Q000235:genetics / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000378:metabolism*
chemical_list: D057134:Antibodies, Neutralizing; D051197:Toll-Like Receptor 4; D014409:Tumor Necrosis Factor-alpha